未登录 Progesterone receptor (PR) intra-tumor heterogeneity in premenopausal breast cancer: A secondary analysis of a randomized trial 孕酮受体（PR）在绝经前乳腺癌中的肿瘤内异质性：一项随机试验的二次分析 Danielsson, Oscar; Dar, Huma; Perez-Tenorio, Gizeh; Nordenskjold, Anna; Yau, Christina; Benz, Christopher C.; Esserman, Laura J.; Nordenskjold, Bo; Stal, Olle; Fornander, Tommy; Hartman, Johan; Tobin, Nicholas P.; Johansson, Annelie; Lindstrom, Linda S. 分享 收藏
Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trial Johansson, Annelie; Dar, Huma; Nordenskjoeld, Anna; Perez-Tenorio, Gizeh; Tobin, Nicholas P.; Yau, Christina; Benz, Christopher C.; Esserman, Laura J.; van 't Veer, Laura J.; Nordenskjoeld, Bo; Stal, Olle; Fornander, Tommy; Lindstroem, Linda S. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Differential long-term benefit of 2-year adjuvant tamoxifen therapy for luminal-type breast cancer: Insights from a 20-year follow-up analysis of the STO trials 2年辅助他莫昔芬疗法对腔型乳腺癌的长期差异化益处：来自STO试验20年随访分析的见解 Romero, M. Rios; Danielsson, O.; Fornander, T.; Nordenskjold, A.; Tenorio, G. Perez; Tobin, N. P.; Nordenskjold, B. A.; Stal, O.; Esserman, L.; Van't Veer, L. J.; Lindstrom, L. S. 分享 收藏
Long-term tamoxifen benefit in pre- and postmenopausal patients of high and low risk with luminal A and B breast cancer luminal A型和B型乳腺癌高危和低危绝经前及绝经后患者长期他莫昔芬的获益 Danielsson, O.; Dar, H. A.; Nordenskjold, A.; Tenorio, G. Perez; Yau, C.; Benz, C.; Van't Veer, L. J.; Esserman, L.; Nordenskjold, B. A.; Fornander, T.; Stal, O.; Tobin, N. P.; Johansson, A.; Lindstrom, L. S. 分享 收藏
Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy Nordenskjold, Anna; Fohlin, Helena; Rosell, Johan; Bengtsson, Nils-Olof; Fornander, Tommy; Hatschek, Thomas; Lindman, Henrik; Malmstrom, Per; Ryden, Lisa; Wallgren, Arne; Stal, Olle; Nordenskjold, Bo 分享 收藏
Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial Lundgren, Christine; Tutzauer, Julia; Church, Sarah E.; Stal, Olle; Ekholm, Maria; Forsare, Carina; Nordenskjold, Bo; Ferno, Marten; Bendahl, Par-Ola; Ryden, Lisa 分享 收藏
Long-term survival and intra-tumor heterogeneity of progesterone receptor expression in estrogen receptor-positive/progesterone receptor-positive premenopausal women with breast cancer Danielsson, Oscar; Dar, Huma; Perez-Tenorio, Gizeh; Nordenskjold, Anna; Yau, Christina; Benz, Christopher C.; Esserman, Laura J.; Nordenskjold, Bo; Stal, Olle; Fornander, Tommy; Johansson, Annelie; Lindstrom, Linda S. 分享 收藏
Long-Term Benefit from Adjuvant Tamoxifen in Luminal A and Luminal B Breast Cancer Patients Dar, Huma; Johansson, Annelie; Nordenskjold, Anna; Perez-Tenorio, Gizeh; Yau, Christina; Benz, Christopher C.; Esserman, Laura J.; Nordenskjold, Bo; Stal, Olle; Fornander, Tommy; Lindstrom, Linda S. 分享 收藏
Differential Long-Term Benefit from Adjuvant Tamoxifen Therapy in Estrogen Receptor (ER)-Positive/Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Premenopausal and Postmenopausal Breast Cancer Patients Johansson, Annelie; Dar, Huma; Nordenskjold, Anna; Perez-Tenorio, Gizeh; Yau, Christina; Benz, Christopher C.; Esserman, Laura J.; Van't Veer, Laura; Nordenskjold, Bo; Stal, Olle; Fornander, Tommy; Lindstrom, Linda S. 分享 收藏
PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients Lundgren, Christine; Bendahl, Par-Ola; Church, Sarah E.; Ekholm, Maria; Ferno, Marten; Forsare, Carina; Kruger, Ute; Nordenskjold, Bo; Stal, Olle; Ryden, Lisa 分享 收藏
20-year tamoxifen benefit in ER-positive/HER2-negative breast cancer patients in randomized clinical trials Dar, H. A.; Johansson, A.; Nordenskjold, A.; Yau, C.; Benz, C.; Essermann, L.; Rodriguez-Wallberg, K. A.; Nordenskjold, B. A.; Perez-Tenorio, G.; Stal, O.; Fornander, T.; Lindstrom, L. 分享 收藏
Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature Johansson, Annelie; Yu, Nancy Y.; Iftimi, Adina; Tobin, Nicholas P.; 't Veer, Laura; Nordenskjold, Bo; Benz, Christopher C.; Fornander, Tommy; Perez-Tenorio, Gizeh; Stal, Olle; Esserman, Laura J.; Yau, Christina; Lindstrom, Linda S. 分享 收藏
分享 收藏
Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up Chamalidou, C.; Fohlin, H.; Albertsson, P.; Arnesson, L. -G.; Einbeigi, Z.; Holmberg, E.; Nordenskjold, A.; Nordenskjold, B.; Karlsson, P.; Linderholm, B. 分享 收藏
20-year benefit of endocrine therapy in premenopausal breast cancer patients by the 70-gene risk signature Johansson, A.; Dar, H.; Van'T Veer, L.; Perez-Tenorio, G.; Nordenskjold, A.; Yau, C.; Benz, C.; Esserman, L.; Stal, O.; Nordenskjold, B.; Fornander, T.; Lindstrom, L. 分享 收藏
25-year survival and benefit from tamoxifen therapy by the clinically used breast cancer markers in lymph node-negative and ER-positive/HER2-negative breast cancer Dar, H. A.; Johansson, A.; Nordenskoljd, A.; Iftimi, A.; Yau, C.; Perez-Tenorio, G.; Benz, C.; Nordenskjold, B.; Stal, O.; Esserman, L.; Fornander, T.; Lindstrom, L. 分享 收藏
MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit Lokkegaard, Sanne; Elias, Daniel; Alves, Carla L.; Bennetzen, Martin V.; Laenkholm, Anne-Vibeke; Bak, Martin; Gjerstorff, Morten F.; Johansen, Lene E.; Vever, Henriette; Bjerre, Christina; Kirkegaard, Tove; Nordenskjoeld, Bo; Fornander, Tommy; Stal, Olle; Lindstroem, Linda S.; Esserman, Laura J.; Lykkesfeldt, Anne E.; Andersen, Jens S.; Leth-Larsen, Rikke; Ditzel, Henrik J. 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
